Additionally, it can hinder the activation and proliferation of hepatic stellate cells by targeting the toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) signal pathway, thereby slowing down the progression of liver fibrosis [183]. The gene discussed is TLR4; the disease is Hepatic fibrosis.